过敏性支气管肺部菌根症由Schizophyllum commune引起 已成功用Mepolizumab治疗
Mitsuki Kakiuchi1, Yuki Takigawa1, Ken Sato1
1Department of Respiratory Medicine National Hospital Organization Okayama Medical Center Okayama Japan.
当标准疗法失败时,梅波利祖马布有效地治疗了一名过敏性支气管肺髓瘤 (ABPM) 和严重支气管喘 (BA) 的患者. 这种生物疗法清除了粘液塞,改善了呼吸道症状.
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 临床案例研究临床案例研究
背景情况:
- 过敏性支气管肺部菌 (ABPM) 是支气管喘 (BA) 的严重并发症,可能导致肺损伤和呼吸衰竭.
- 对ABPM的标准类固醇治疗具有感染和骨质疏松症等风险,需要探索替代治疗方法.
- 耐火性BA和ABPM带来了重大的临床挑战,突出了对新型治疗策略的需求.
研究的目的:
- 报告一例ABPM和耐火性BA成功用mepolizumab治疗的病例.
- 为了评估mepolizumab在患有持续粘液堵塞和呼吸系统损害的患者中的疗效.
主要方法:
- 一名70岁的男性患者有BA病史,出现了急性发作.
- 包括计算机断层扫描和实验室测试在内的诊断工作证实了ABPM;最初使用类固醇和伊特拉可纳治疗无效.
- 针对耐火性症状和持续性粘液塞,开始了mepolizumab (100 mg/月) 的皮下给药.
主要成果:
- 梅波利祖马布治疗导致粘液塞的清除.
- 在开始服用梅波利祖马布后,人们观察到支气管喘症状的显著改善,包括减少喘息和改善氧气和.
- 患者从梅波利祖马布治疗中获得了持续的临床益处.
结论:
- 梅波利祖马布显示出作为ABPM和耐火BA.患者有效治疗的潜力.
- 用美波利祖马布进行的生物治疗为管理对传统治疗无反应的复杂ABPM病例提供了一个有希望的替代方案.
更多相关视频
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
09:52Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
相关概念视频
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma-I: Introduction
Other Pulmonary Disorders
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
